Equities
  • Price (USD)78.99
  • Today's Change-3.30 / -4.01%
  • Shares traded586.00
  • 1 Year change+51.88%
  • Beta0.8265
Data delayed at least 15 minutes, as of Feb 06 2026 20:14 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and, consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain.

  • Revenue in EUR (TTM)7.30bn
  • Net income in EUR475.00m
  • Incorporated2012
  • Employees65.00k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ERF:PAR since
announced
Transaction
value
Ac.Biomed GmbHAnnounced16 Oct 202516 Oct 2025Announced9.96%--
Planton GmbHDeal completed20 May 202520 May 2025Deal completed21.69%--
Data delayed at least 15 minutes, as of Feb 06 2026 16:35 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.